DESIPRAMINE HYDROCHLORIDE (desipramine hydrochloride) by ANI Pharmaceuticals is clinical pharmacology mechanism of action available evidence suggests that many depressions have a biochemical basis in the form of a relative deficiency of neurotransmitters such as norepinephrine and serotonin. Approved for depression. First approved in 1997.
Drug data last refreshed 21h ago
CLINICAL PHARMACOLOGY Mechanism of Action Available evidence suggests that many depressions have a biochemical basis in the form of a relative deficiency of neurotransmitters such as norepinephrine and serotonin. Norepinephrine deficiency may be associated with relatively low urinary 3-methoxy-4-…
Worked on DESIPRAMINE HYDROCHLORIDE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets